Neuroimaging and Surgery
Neuroimaging studies included magnetic resonance imaging and/or computed tomography (in the first years); such studies were available in only 85 cases. We noted the destruction of surrounding bones and the patterns of extension into the supra-or parasellar regions, cavernous sinus, middle or posterior cranial fossa, cerebellopontine angle, foramen magnum, or outside the cranium. The aim of surgery in all cases was maximally safe tumor removal and decompression of neural structures. A surgery planned and performed in two steps was considered as one procedure in our analysis. Radicality of tumor removal was defined by the surgeon at the end of operation and confirmed on the basis of postoperative imaging studies. Tumor removal was defined as total or subtotal.
Surgical Approaches
Operative approaches were selected on the basis of the predominant tumor extension. The most frequently used approaches included the transethmoidal, pterional, and retrosigmoid. As details of the surgical techniques have been presented elsewhere, 32, 33, 41 we describe only the main steps here.
In the transethmoidal approach the skin was incised paranasally. The nasolacrimal duct was dissected and an ethmoidectomy was performed so that the sphenoid sinus and clival region were exposed. To decrease the risk of CSF leakage in cases of dural penetration by the tumor or surgical opening of the dura mater, a fat graft was placed after tumor removal.
The pterional approach included a standard frontotemporal craniotomy and extradural removal of the sphenoid ridge with a high-speed drill. The dura was incised in a semicircular manner with a base toward the sphenoid ridge. Opening of the sylvian fissure ensured that minimal retraction was applied to healthy brain.
The retrosigmoid approach was performed with the patient in a semi-sitting position. In all cases continuous electromyography of the facial nerve and auditory brainstem potentials was performed. Precordial Doppler echography monitoring was used for early detection of venous air embolism. A retrosigmoid craniotomy, exposing the borders of the transverse and sigmoid sinuses, was performed. The dural incision was C-shaped along the sinuses. Evacuation of CSF from the lateral cerebellomedullary cistern allowed wide exposure of the tumor without compromising the cerebellar hemisphere.
Statistical Analysis
The Kaplan-Meier analysis was applied to determine patient survival rates 5 and 10 years after their initial surgery. 17 A comparison of the survival rates in patients subjected to different forms of treatment was performed. The chi-square test was used for statistical analysis of the findings. 40 Statistical significance was set at a probability value less than or equal to 0.05.
Results

Clinical Features
The average age of patients on the appearance of initial symptoms was 38.3 years (range 10-65 years). At the time of diagnosis the average patient age was 39.1 years. The most frequent initial sign was abducent nerve palsy in 23 patients (46.9%), followed by oculomotor nerve palsy, headache, and vertigo in three cases each (Table 1) . The period between initial signs and diagnosis was 10 months (range 1-72 months).
Tumor Growth Pattern
Approximately half of the tumors (54%) exhibited supra-or parasellar growth. The most frequent direction of tumor growth was into the posterior cranial fossa (81%). In one third of the patients (35%) the brainstem was compressed. Computed tomography examinations showed evidence of clival destruction in all cases.
Surgical Procedure
The total number of surgeries was 116; 93 of these were performed in Hannover. A variety of operative approaches were used; the approach in each case was tailored to the extension pattern of the tumor. The approach used most frequently was the transethmoidal in 28 cases (30.1%), followed by the pterional in 18 cases (19.3%) and the retrosigmoid in 18 cases (19.3%). In the other cases the subtemporal, bifrontal, transfacial, subtemporal-suboccipital, transoraltransmaxillary, presigmoid, or frontolateral approach was used. In eight cases a planned two-stage surgery via different approaches was performed.
The chordoma was removed totally in 42 cases (49.4%) and subtotally in 43 cases (50.6%). The rate of total removal was highest at the initial surgery (78%) and declined progressively thereafter.
In 11 cases (11.8%) a new neurological deficit developed, while the preoperative deficit remained unchanged. In 15 cases (16.1%) the preoperative deficit improved, but a new deficit also appeared. The types of deficits and their relation to the individual surgical approaches are presented in Table 2 . Cerebrospinal fluid leaks were noted in 5.4% of cases, usually following the initial surgery (Table 3) . Postoperative hemorrhage occurred in 4.3%, hydrocephalus in 7.5%, and diffuse brain edema in 1.1% of cases. These complications tended to develop after the second reoperation. The only death in this series of patients was due to severe sepsis, which occurred after the second reoperation.
Histological Features
In 52 cases the tumor was not solid, whereas in nine cases it was solid. In two cases chondroid chordoma was diagnosed. The tumor tissue stained positively for vimentin and the epithelial markers pancytokeratin and cytokeratin.
Follow-Up Study
Long-term follow-up data were available in 37 patients (75.5%). The average follow-up in the group was 63 months. Twenty patients (54%) died an average of 49 months (range 5-134 months) after the initial surgery. The most frequent cause of death was further tumor growth (50%).
At the time of the last follow-up examination, 17 patients were still alive, an average of 78 months (range 19-204 months) after the initial surgery. Eight of them had undergone one surgery and nine had undergone multiple sur-geries. The average Karnofsky Performance Scale score was 84% (range 20-100%). The preoperative abducent nerve palsy improved in four of six cases (Table 4) . Still, the most frequent symptom was double vision due to abducent nerve palsy (in three patients). Twenty-five percent of these patients had no neurological deficit or symptoms and 255 had mild symptoms. The average survival period in patients who had undergone one surgery was 46 months (range 19-79 months). At the last magnetic resonance imaging follow-up examination in five of them, there was no evidence of tumor growth. The patients who had undergone several surgeries had an average survival of 106 months after their initial surgery (range 46-206 months); no evidence of tumor growth was found in eight of these patients.
Radiation Therapy
Radiotherapy was performed in 19 patients. In four patients it was performed twice. The type of irradiation differed: seven patients received conventional radiotherapy, one combined conventional and stereotactic, nine stereotactic radiotherapy, and four radiosurgery. In two patients the type of irradiation was not known.
Patient Outcome
The 5-and 10-year survival rates were 65 and 39%, respectively. Male patients who died before the follow-up survived an average of 70 months (range 5-170 months); females survived an average of 45 months (range 8-81 months). If the patient was older than 40 years at the initial diagnosis, survival lasted 63 months. In younger patients survival was shorter: 48 months. The recurrence-free interval was longer in the group of patients who had undergone radical tumor removal (Fig. 1) . Among patients who received postoperative radiotherapy, the recurrence-free interval was longest in those who also underwent subtotal removal. This association was not statistically significant, however.
Discussion
Chordomas originate from the remnants of the embryonic notochord along the neural axis. They occur in the axial skeleton, most frequently in the sacrococcygeal region (50%), sphenooccipital synchondrosis (35%), and vertebral regions (15%). 12, 13, 38 Chordomas have a slight male predilection, with a male/ female ratio of 2:1. 7, 8, 12, 20, 22 Although these lesions have been reported in all age groups, the peak incidence is in the fourth decade. 5, 13, 20, 22 The average age of patients in the present study on the first appearance of symptoms was 38.3 years, which corresponds to the average age reported by Al Mefty and Borba, 1 Heffelfinger et al., 12 and Stuer et al., 37 but is significantly lower than the average age reported by Crockard et al. 8 (58.1 years). The first sign of the disease is usually an isolated abducent nerve palsy: in 46% of cases according to Volpe et Chordomas are very difficult to treat and typically have a poor prognosis. Their optimal management remains a matter of controversy. The definitions of total, near-total, radical, and subtotal removal in the various studies differ, making direct comparisons of results impossible.
An aggressive surgical approach to chordomas has been favored by some surgeons 7, 11, 19, 35, 36 based on the assumption that longer survival rates have been associated with more extensive tumor removal. 11, 36 To postpone recurrences Gay et al. 11 proposed aggressive and extensive tumor removal, especially at the initial surgery and if no previous radiotherapy has been administered. In these authors' series of 46 patients radical removal was achieved in 67%, but the complication rate was relatively high. Abducent nerve palsy occurred in 28%, hearing loss in 15%, permanent facial palsy in 8%, and visual decline or loss in 8%. In 30% of cases a CSF leak was noted. Sekhar and colleagues, 35 having experience with 42 cases, proposed complete tumor removal, especially in medically fit patients who have not undergone previous surgery. They achieved total removal in 59% of patients at the expense of considerable morbidity rates: 26%, CSF leak; 12%, vessel injury; 33%, new cranial nerve deficit; and 12%, perioperative death. Al Mefty and colleagues 1, 7 have also asserted that extensive excision has an important role in the management of chordomas. In their series of 53 patients radical/subtotal tumor removal was performed in more than 77%. Analyzing the outcome, they found that the 5-year survival rate was 85.9% in typical and 87.8% in chondroid chordomas. Surgery-related complications were observed in 60.3% of patients and neurological complications in 58.7% of patients. Sen and Triana 36 attempted total resection of the tumor and surrounding bone; in 18 of 29 cases they achieved total removal. Nevertheless, the mean time to recurrence after the last surgery among the patients was 16.3 months.
In contrast, true oncological resection of chordoma can hardly, if ever, be achieved. 8, 18, 30 Long-term survival rates and recurrence-free intervals have not been substantially prolonged after extensive surgeries. Aggressive tumor resection is accompanied by a significant procedure-related morbidity rate. An alternative surgical strategy has been proposed: safe cytoreductive resection. The goal is to remove as much of the tumor as possible with the lowest morbidity rates and to ensure a good postoperative quality of life. 8, 18, 37 Crockard and colleagues 8 proposed as a surgical goal maximum safe cytoreduction, with the least collateral damage. They most frequently used the ventral extradural approaches, but for laterally extending tumors they preferred the infratemporal fossa approach combined with a transpetrosal or far-lateral approach. In a series of 42 patients these authors achieved total or radical removal in 32 cases, with a 4.2% surgical mortality rate. The rate of CSF leakage was 21% at the first surgery and 56% at reoperations. Note that meningitis developed in 8% of cases, possibly due to the approach used.
The 5-year survival rate among patients in the present study was 65%, which is similar to results presented by other neurosurgeons. 4, 8, 11 According to our data, radical surgery does not increase survival statistically significantly. As the quest for radicality is related to higher morbidity rates, we propose as the treatment goal not only radical tumor removal, but also preservation of neurological functions. Contrary to more aggressive management strategies, we found that similar survival times with a better quality of life can be achieved by using less extensive therapy. Surgical removal should permit decompression of neurovascular structures so that safe and more efficient radiotherapy can be performed.
A variety of operative approaches have been used successfully to remove chordomas. The approach among patients in the present series was chosen individually in accordance with the tumor extension pattern. The approaches most frequently used were the transethmoidal, the pterional, and the retrosigmoid. The transethmoidal approach was used in more than one third of cases; it is a safe approach that offers good access to the tumor, especially if the sphenoid sinus is invaded. The retrosigmoid approach was especially useful in tumors growing into the cerebellopontine angle. Chordomas located at the upper clival region and extending to the temporal region were best removed via the pterional approach.
Prognostic Factors
Forsyth and associates 10 and Weber et al. 39 found that age is the most important predictive variable. Patients younger than 40 years old survived longer than the older patients. 21 Contrary to these data we found that the outcome is better in patients older than 40 years of age, although the results were not statistically significant. We found that the outcome is better in male patients, which corresponds to the findings of other surgeons. 23, 29 Among other predictive factors discussed in the literature are the presence of diplopia, 10 tumor volume 15, 29 and histological features, 12,14 radicality of surgery, extent of tumor removal at the first surgery, 8 and delivered radiation dose. 21 In previously published studies we found that nuclear pleomorphism, p53 overexpression, and abnormalities of the G1 checkpoint are associated with a worse prognosis. [25] [26] [27] [28] [29] In contrast, nuclear pleomorphism, patient age, and recurrence rate appeared to be closely related to the proliferative ability of chordomas.
Radiation Therapy
The effectiveness of radiotherapy is related to the dose applied. The tumor control rate in the series of Pearlman and Friedman 31 is 80% in patients receiving more than 80 Gy and only 20% in those receiving a dose of 40 to 60 Gy. In contrast, the proximity of chordoma to vital neural structures limits the role of conventional radiotherapy. Irradiation with heavy particles (protons, carbon ions, helium, and combined proton-photon or carbon-photon therapy) as well as stereotactic conventional irradiation has been shown to have greater effectiveness. 4, 6, 9, 15, 16, 24, 32 The 5-year actuarial tumor control rate ranges from 68 to 85%. 3, 15, 23 The 5-year survival rate in a series described by Munzenrider and Liebsch 23 was 85% for male and 65% for female patients; the 10-year survival rate was 65 and 42%, respectively.
The volume and location of residual tumor is related to the effectiveness of radiotherapy. Austin and associates Statistical analysis of our results revealed that if radiotherapy is performed, there is a tendency toward a better outcome and prolongation of the intervals between reoperations. It is difficult to draw definitive conclusions regarding the efficacy of different radiotherapeutic modalities because of the heterogeneity of our series in this regard. However, data in the existing literature strongly suggest that performing such adjuvant therapy after surgery for chordoma is effective. The exact timing of radiotherapy remains controversial. Some authors suggest that radiotherapy is more effective when administered immediately after surgery than if given after tumor recurrence. 2 Crockard and colleagues 8 based their decision to proceed with radiotherapy on the histological characteristics of the tumor. If few mitotic figures and Ki 67 levels lower than 6% are found after the first surgery, they do not perform radiotherapy. All other patients are treated with radiotherapy. Note, however, that surgery after radiotherapy is related to a higher morbidity rate.
Conclusions
With an individually tailored approach, total tumor removal was achieved in 78% of the cases at the initial surgery. Radical surgery appears to increase slightly the surgical morbidity, although the recurrence-free interval is prolonged. Chordomas cannot be regarded as surgically curable tumors given their associated 5-and 10-year survival rates; therefore, adjuvant radiotherapy must be systematically pursued. FIG. 1 . Graph depicting the recurrence-free interval after radical and subtotal tumor removal. Prolonged survival after radical removal is not statistically significant. Time is measured in months; cumulative (Cum.) survival, in percentages.
